Abnormal dexamethasone suppression test in primary obsessive-compulsive patients: a confirmatory report

Area of Science:

• Neuroscience
• Psychiatry
• Endocrinology

Background:

• Obsessive-compulsive disorder (OCD) is a debilitating mental health condition.
• The dexamethasone suppression test (DST) is used to assess hypothalamic-pituitary-adrenal (HPA) axis function.
• Abnormal DST results are often associated with depression.

Purpose of the Study:

• To investigate DST abnormalities in patients with OCD.
• To explore the relationship between DST results and clinical characteristics in OCD patients.
• To examine the potential link between OCD, depression, and HPA axis dysregulation.

Main Methods:

• Administered the DST to 20 patients meeting DSM-III criteria for OCD.
• Measured baseline and post-dexamethasone cortisol levels.
• Assessed demographic data, depressive symptoms, and OCD severity.

Main Results:

• 30% of OCD patients exhibited abnormal DST results (nonsuppressors).
• No significant differences were found between suppressors and nonsuppressors regarding age, secondary depression, or psychometric scores.
• A trend suggested a stronger family history of depression in suppressors and more males among nonsuppressors.
• A significant correlation existed between pre- and post-DST cortisol levels.
• Five of six nonsuppressors showed symptom improvement with antidepressant therapy.

Conclusions:

• The DST may identify a subset of OCD patients with HPA axis dysregulation.
• Findings suggest a potential overlap or relationship between OCD and endogenous depression.
• The specificity of the DST in differentiating between these conditions warrants further investigation.